CDH1 and breast cancer: In 1997, Restucci and coworkers evaluated for the first time the immunohistochemical E-cadherin expression in canine mammary tumours, describing a reduced membranous expression in malignant neoplasia [33], especially in poorly undifferentiated cases, which was later on confirmed by other groups [35, 40], but not by others [42].